Up 45% YTD, Should You Buy This Outperforming Healthcare Stock? Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks. Barchart · Oct 31, 2024
Earnings Preview: What To Expect from Boston Scientific's Report With Boston Scientific gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings growth. Barchart · Oct 9, 2024
3 'Strong Buy' Stocks to Grab Now for More Gains For investors looking to add some high-potential stocks to their portfolio, here are three top-rated opportunities to consider now. Barchart · Sep 5, 2024
Is Boston Scientific Stock Outperforming the Nasdaq? Boston Scientific has outperformed the Nasdaq Composite over the past year, and analysts remain bullish on the stock’s prospects. Barchart · Sep 3, 2024
'I'm on morphine patches every day': Woman still waiting for vaginal mesh removal four years later ‘I used to walk everywhere, but now I just potter around the house. I no longer walk to the shops,’ June Dunne tells Maya Oppenheim The Independent UK · Aug 28, 2024
Women harmed by vaginal mesh in England get payout The amount of the financial settlement has not been made public, although it is expected millions have been paid out Evening Standard · Aug 21, 2024
140 women win payouts for vaginal mesh complications Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating The Independent UK · Aug 19, 2024
140 women in England receive payout for vaginal mesh implant complications Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown The Guardian - UK · Aug 19, 2024
What Are Wall Street Analysts' Target Price for Boston Scientific Stock? Boston Scientific has outperformed the broader market over the past year, and analysts remain bullish about the stock’s prospects. Barchart · Aug 6, 2024
How Boston Scientific's digital and IT boss upgraded her team from order takers to strategic thinkers The $110 billion medical devices company now has a digital leader who sits on the executive management board of every division, every region, and every business function. Fortune · Jul 31, 2024
Boston Scientific's Quarterly Earnings Preview: What You Need to Know Boston Scientific is expected to report its second-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth. Barchart · Jul 12, 2024
Is Boston Scientific Stock Outperforming the S&P 500? Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects. Barchart · Jun 11, 2024
Boston Scientific Stock: Is Wall Street Bullish or Bearish? Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects. Barchart · May 16, 2024
3 Safe Haven Stocks to Own in an Unpredictable Market Even though 2024 kicked off strong, recent macroeconomic uncertainties highlight the need for resilient investments. These three “safe haven” stocks are worth considering for hedging against the market downswings. Barchart · Apr 17, 2024
StockNews.com · Jan 29, 2024 Smith & Nephew (SNN) vs. Boston Scientific (BSX): Buy or Sell as These Medical Stocks Gear up for Quarterly Earnings? The medical devices and equipment industry is primed to make significant strides toward growth this year, a surge propelled by increasing incidences of chronic diseases and the emphasis on early detection and treatment, coupled with leaps in technological development. Given this backdrop, let’s compare medical device stocks Boston Scientific (BSX)…
Barchart · Jan 18, 2024 Chart of the Day: Boston Scientific - Revenue Growth Potential The Chart of the Day belongs to the healthcare company Boston Scientific (BSX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...
Barchart · Jan 18, 2024 Chart of the Day: Boson Scientific - Revenue Growth Potential The Chart of the Day belongs to the healthcare company Boston Scientific (BSX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...
Barchart · Jan 8, 2024 Markets Today: Stocks Climb on M&A Activity and Lower Bond Yields Morning Markets March E-Mini S&P 500 futures (ES H24) are up +0.06%, and March Nasdaq 100 E-Mini futures (NQH2 4) are up +0.18%. Stock index futures this morning are moderately higher. An increase in M&A activity supports stocks after Boston Scientific agreed to buy Axionics for $3.7 billion and Johnson...
Barchart · Oct 24, 2023 3 Top-Rated Growth Stocks To Buy on Every Dip Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.
Barchart · May 15, 2023 Chart of the Day: Boston Scientific - Medical Technology The Chart of the Day belongs to the medical technology company Boston Scientific (BSX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the...
Tribune News Service · Feb 2, 2023 Texas biotech company, UT win $42 million patent case against Boston Scientific A small Dallas biotech company and the University of Texas took on big pharma and won.
The Guardian - AU · Sep 12, 2022 Johnson & Johnson reaches $300m settlement over pelvic mesh implants Settlement of two Australian class actions is largest in country’s history and subject to federal court approval
Benzinga · Aug 16, 2022 Coinbase Global, T-Mobile US And 2 Other Stocks Insiders Are Selling U.S. crude oil futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades.
Benzinga · Jul 19, 2022 Accenture And 3 Other Stocks Insiders Are Selling Johnson & Johnson (NYSE: JNJ) reported upbeat earnings for its second quarter, but lowered its FY22 guidance. Investors, meanwhile, focused on some notable insider trades.
The Guardian - AU · Jul 13, 2022 Boston Scientific to pay $105m to Australian women who received pelvic mesh implants Lawyer says settlement will provide compensation for women who suffered pain and complications from pelvic mesh